Chugai Pharmaceutical Revenue

In the year 2025, Chugai Pharmaceutical had annual revenue of 1.26T JPY with 7.46% growth. Chugai Pharmaceutical had revenue of 343.50B in the quarter ending December 31, 2025, with 13.71% growth.

Revenue

1,257.94B

Revenue Growth

+7.46%

P/S Ratio

12.40

Revenue / Employee

250.29M

Employees

7,872

Market Cap

15.60T

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1,257.94B	87.33B	7.46%
Dec 31, 2024	1,170.61B	59.24B	5.33%
Dec 31, 2023	1,111.37B	-148.58B	-11.79%
Dec 31, 2022	1,259.95B	260.19B	26.02%
Dec 31, 2021	999.76B	212.81B	27.04%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Daiichi Sankyo Company	2,052.15B
Otsuka Holdings	2,468.89B
Astellas Pharma	2,060.61B
Ono Pharmaceutical	509.35B
Kyowa Kirin	496.83B
Santen Pharmaceutical	287.99B
JCR Pharmaceuticals	37.55B
Perseus Proteomics	140.41M

Revenue Rankings

Chugai Pharmaceutical News

4 weeks ago - Japanese drugmakers slump after Trump unveils discount drug website - Reuters

More News